Artificial intelligence brings pancreatic cancer screening one step closer to reality
Artificial intelligence (AI) holds promise for enabling earlier detection of pancreatic cancer, which is crucial to saving lives. The potential of AI is showcased in a study to be presented at the ESMO World Congress on Gastrointestinal Cancer, 1–4 July 2020. Overall, 12 in every 100,000 people develop pancreatic cancer. This means that screening everyone would be inefficient and would […]
Continue reading »